Xeljanz and pulmonary embolism and pulmonary thrombosis

Xeljanz is a drug used to treat rheumatoid arthritis and ulcerative colitis. Unfortunately, after Xeljanz was approved the FDA issued a safety warning on the drug, regarding an increased risk of blood clots and of death with the 10 mg twice daily dose of Xeljanz.

If you have taken the 10mg twice daily dose of Xeljanz and experienced a pulmonary embolism, pulmonary thrombosis, or deep-vein thrombosis, the drug company may be liable for your injury. Fill out the form below, and an attorney will assess your case.